Article info
PDFReview
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects
- Correspondence to Dr Andrea Cortese, Neuromuscular diseases, University College London Institute of Neurology, London, UK; andrea.cortese{at}ucl.ac.uk; Professor Mary M Reilly; m.reilly{at}ucl.ac.uk
Citation
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects
Publication history
- Accepted May 28, 2021
- First published August 13, 2021.
Online issue publication
January 20, 2022
Article Versions
- Previous version (13 August 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia
- Sensory neuronopathies: new genes, new antibodies and new concepts
- RFC1-related ataxia is a mimic of early multiple system atrophy
- Diagnosis and management of progressive ataxia in adults
- RFC1 CANVAS: the expanding phenotype
- 15.45 Recessive pentanucleotide repeat expansion in RFC1 causes CANVAS and late-onset sensory ataxia
- Downbeat nystagmus: aetiology and comorbidity in 117 patients
- Peripheral neuropathy in complex inherited diseases: an approach to diagnosis
- Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic
- Will genetic panels replace clinical skills?